{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:02:49Z","timestamp":1793278969939,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11914-017-0344-5","type":"journal-article","created":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T09:40:48Z","timestamp":1486201248000},"page":"18-23","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["The Role of TGF\u03b2 in Bone-Muscle Crosstalk"],"prefix":"10.1007","volume":"15","author":[{"given":"Jenna N.","family":"Regan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trupti","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa A.","family":"Guise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Waning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,4]]},"reference":[{"issue":"27","key":"344_CR1","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1016\/S0021-9258(18)67143-1","volume":"261","author":"PV Hauschka","year":"1986","unstructured":"Hauschka PV, Mavrakos AE, Iafrati MD, Doleman SE, Klagsbrun M. Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-sepharose. J Biol Chem. 1986;261(27):12665\u201374.","journal-title":"J Biol Chem"},{"issue":"1","key":"344_CR2","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-14-0584","volume":"225","author":"KJ Oldknow","year":"2015","unstructured":"Oldknow KJ, MacRae VE, Farquharson C. Endocrine role of bone: recent and emerging perspectives beyond osteocalcin. J Endocrinol. 2015;225(1):R1\u201319. doi: 10.1530\/JOE-14-0584 .","journal-title":"J Endocrinol"},{"issue":"2","key":"344_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11154-014-9307-7","volume":"16","author":"J Wei","year":"2015","unstructured":"Wei J, Karsenty G. An overview of the metabolic functions of osteocalcin. Rev Endocr Metab Disord. 2015;16(2):93\u20138. doi: 10.1007\/s11154-014-9307-7 .","journal-title":"Rev Endocr Metab Disord"},{"key":"344_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.semcdb.2015.11.007","volume":"49","author":"JN Regan","year":"2016","unstructured":"Regan JN, Waning DL, Guise TA. Skeletal muscle Ca(2+) mishandling: another effect of bone-to-muscle signaling. Semin Cell Dev Biol. 2016;49:24\u20139. doi: 10.1016\/j.semcdb.2015.11.007 .","journal-title":"Semin Cell Dev Biol"},{"key":"344_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bone.2014.03.008","volume":"64","author":"I Levinger","year":"2014","unstructured":"\u2022 Levinger I, Scott D, Nicholson GC, Stuart AL, Duque G, McCorquodale T, et al. Undercarboxylated osteocalcin, muscle strength and indices of bone health in older women. Bone. 2014;64:8\u201312. doi: 10.1016\/j.bone.2014.03.008 . This study shows an age-adjusted association between lower limb strength and osteocalcin in humans","journal-title":"Bone"},{"issue":"2","key":"344_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","volume":"142","author":"M Ferron","year":"2010","unstructured":"Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, Teti A, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell. 2010;142(2):296\u2013308. doi: 10.1016\/j.cell.2010.06.003 .","journal-title":"Cell"},{"issue":"2","key":"344_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.cell.2010.06.002","volume":"142","author":"K Fulzele","year":"2010","unstructured":"Fulzele K, Riddle RC, DiGirolamo DJ, Cao X, Wan C, Chen D, et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell. 2010;142(2):309\u201319. doi: 10.1016\/j.cell.2010.06.002 .","journal-title":"Cell"},{"issue":"3","key":"344_CR8","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","volume":"130","author":"NK Lee","year":"2007","unstructured":"Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130(3):456\u201369. doi: 10.1016\/j.cell.2007.05.047 .","journal-title":"Cell"},{"issue":"4","key":"344_CR9","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/jbmr.2389","volume":"30","author":"H Shen","year":"2015","unstructured":"Shen H, Grimston S, Civitelli R, Thomopoulos S. Deletion of connexin43 in osteoblasts\/osteocytes leads to impaired muscle formation in mice. J Bone Miner Res. 2015;30(4):596\u2013605. doi: 10.1002\/jbmr.2389 .","journal-title":"J Bone Miner Res"},{"issue":"2","key":"344_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/jbm.a.31085","volume":"81","author":"B Wildemann","year":"2007","unstructured":"Wildemann B, Kadow-Romacker A, Haas NP, Schmidmaier G. Quantification of various growth factors in different demineralized bone matrix preparations. J Biomed Mater Res A. 2007;81(2):437\u201342. doi: 10.1002\/jbm.a.31085 .","journal-title":"J Biomed Mater Res A"},{"issue":"1","key":"344_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2044-5040-1-4","volume":"1","author":"S Schiaffino","year":"2011","unstructured":"Schiaffino S, Mammucari C. Regulation of skeletal muscle growth by the IGF1-Akt\/PKB pathway: insights from genetic models. Skelet Muscle. 2011;1(1):4. doi: 10.1186\/2044-5040-1-4 .","journal-title":"Skelet Muscle"},{"issue":"11","key":"344_CR12","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1096\/fj.09-131870","volume":"23","author":"B Blaauw","year":"2009","unstructured":"Blaauw B, Canato M, Agatea L, Toniolo L, Mammucari C, Masiero E, et al. Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation. FASEB J. 2009;23(11):3896\u2013905. doi: 10.1096\/fj.09-131870 .","journal-title":"FASEB J"},{"issue":"11","key":"344_CR13","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/ng.2772","volume":"45","author":"R Sartori","year":"2013","unstructured":"\u2022\u2022 Sartori R, Schirwis E, Blaauw B, Bortolanza S, Zhao J, Enzo E, et al. BMP signaling controls muscle mass. Nat Genet. 2013;45(11):1309\u201318. doi: 10.1038\/ng.2772 . This paper describes the role of BMPs in maintenance of the muscle. Signaling through SMAD1\/5\/8 causes muscle hypertrophy and counteracts muscle atrophy signals through regulation of ubiquitin-mediated protein degradation","journal-title":"Nat Genet"},{"issue":"2","key":"344_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1083\/jcb.201211134","volume":"203","author":"CE Winbanks","year":"2013","unstructured":"Winbanks CE, Chen JL, Qian H, Liu Y, Bernardo BC, Beyer C, et al. The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass. J Cell Biol. 2013;203(2):345\u201357. doi: 10.1083\/jcb.201211134 .","journal-title":"J Cell Biol"},{"issue":"9","key":"344_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tem.2014.06.002","volume":"25","author":"R Sartori","year":"2014","unstructured":"Sartori R, Gregorevic P, Sandri M. TGFbeta and BMP signaling in skeletal muscle: potential significance for muscle-related disease. Trends Endocrinol Metab. 2014;25(9):464\u201371. doi: 10.1016\/j.tem.2014.06.002 .","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"344_CR16","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.bone.2010.08.007","volume":"47","author":"MA Kamel","year":"2010","unstructured":"Kamel MA, Picconi JL, Lara-Castillo N, Johnson ML. Activation of beta-catenin signaling in MLO-Y4 osteocytic cells versus 2\u00a0T3 osteoblastic cells by fluid flow shear stress and PGE2: implications for the study of mechanosensation in bone. Bone. 2010;47(5):872\u201381. doi: 10.1016\/j.bone.2010.08.007 .","journal-title":"Bone"},{"issue":"1","key":"344_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1006\/bbrc.1996.1131","volume":"225","author":"NE Ajubi","year":"1996","unstructured":"Ajubi NE, Klein-Nulend J, Nijweide PJ, Vrijheid-Lammers T, Alblas MJ, Burger EH. Pulsating fluid flow increases prostaglandin production by cultured chicken osteocytes\u2014a cytoskeleton-dependent process. Biochem Biophys Res Commun. 1996;225(1):62\u20138. doi: 10.1006\/bbrc.1996.1131 .","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"344_CR18","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1002\/jbmr.168","volume":"25","author":"Y Kitase","year":"2010","unstructured":"Kitase Y, Barragan L, Qing H, Kondoh S, Jiang JX, Johnson ML, et al. Mechanical induction of PGE2 in osteocytes blocks glucocorticoid-induced apoptosis through both the beta-catenin and PKA pathways. J Bone Miner Res. 2010;25(12):2657\u201368. doi: 10.1002\/jbmr.168 .","journal-title":"J Bone Miner Res"},{"issue":"4","key":"344_CR19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/03008209509010823","volume":"31","author":"SI Harada","year":"1995","unstructured":"Harada SI, Balena R, Rodan GA, Rodan SB. The role of prostaglandins in bone formation. Connect Tissue Res. 1995;31(4):279\u201382.","journal-title":"Connect Tissue Res"},{"issue":"3","key":"344_CR20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/1872208311206030223","volume":"6","author":"C Mo","year":"2012","unstructured":"Mo C, Romero-Suarez S, Bonewald L, Johnson M, Brotto M. Prostaglandin E2: from clinical applications to its potential role in bone-muscle crosstalk and myogenic differentiation. Recent Pat Biotechnol. 2012;6(3):223\u20139.","journal-title":"Recent Pat Biotechnol"},{"issue":"4","key":"344_CR21","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/jbmr.275","volume":"26","author":"Y Aono","year":"2011","unstructured":"Aono Y, Hasegawa H, Yamazaki Y, Shimada T, Fujita T, Yamashita T, et al. Anti-FGF-23 neutralizing antibodies ameliorate muscle weakness and decreased spontaneous movement of Hyp mice. J Bone Miner Res. 2011;26(4):803\u201310. doi: 10.1002\/jbmr.275 .","journal-title":"J Bone Miner Res"},{"issue":"12","key":"344_CR22","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1158\/1078-0432.CCR-13-1590","volume":"20","author":"DL Waning","year":"2014","unstructured":"Waning DL, Guise TA. Molecular mechanisms of bone metastasis and associated muscle weakness. Clin Cancer Res. 2014;20(12):3071\u20137. doi: 10.1158\/1078-0432.CCR-13-1590 .","journal-title":"Clin Cancer Res"},{"key":"344_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fphys.2016.00173","volume":"7","author":"MJ Wacker","year":"2016","unstructured":"Wacker MJ, Touchberry CD, Silswal N, Brotto L, Elmore CJ, Bonewald LF, et al. Skeletal muscle, but not cardiovascular function, is altered in a mouse model of autosomal recessive hypophosphatemic rickets. Front Physiol. 2016;7:173. doi: 10.3389\/fphys.2016.00173 .","journal-title":"Front Physiol"},{"key":"344_CR24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00003086-199001000-00036","volume":"250","author":"LF Bonewald","year":"1990","unstructured":"Bonewald LF, Mundy GR. Role of transforming growth factor-beta in bone remodeling. Clin Orthop Relat Res. 1990;250:261\u201376.","journal-title":"Clin Orthop Relat Res"},{"issue":"24","key":"344_CR25","doi-asserted-by":"publisher","first-page":"21352","DOI":"10.1074\/jbc.M111663200","volume":"277","author":"SL Dallas","year":"2002","unstructured":"\u2022 Dallas SL, Rosser JL, Mundy GR, Bonewald LF, et al. J Biol Chem. 2002;277(24):21352\u201360. doi: 10.1074\/jbc.M111663200 . The release of TGFb from mineralized bone matrix is critical for normal bone remodeling and plays a large role in pathophysiological effects in the bone. This paper provides the mechanism for release of TGFb from bone","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"344_CR26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0303-7207(01)00496-8","volume":"180","author":"R Sakai","year":"2001","unstructured":"Sakai R, Eto Y. Involvement of activin in the regulation of bone metabolism. Mol Cell Endocrinol. 2001;180(1\u20132):183\u20138.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"344_CR27","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1096\/fj.13-245894","volume":"28","author":"JL Chen","year":"2014","unstructured":"Chen JL, Walton KL, Winbanks CE, Murphy KT, Thomson RE, Makanji Y, et al. Elevated expression of activins promotes muscle wasting and cachexia. FASEB J. 2014;28(4):1711\u201323. doi: 10.1096\/fj.13-245894 .","journal-title":"FASEB J"},{"issue":"1","key":"344_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/mus.22232","volume":"45","author":"CL Mendias","year":"2012","unstructured":"\u2022\u2022 Mendias CL, Gumucio JP, Davis ME, Bromley CW, Davis CS, Brooks SV. Transforming growth factor-beta induces skeletal muscle atrophy and fibrosis through the induction of atrogin-1 and scleraxis. Muscle Nerve. 2012;45(1):55\u20139. doi: 10.1002\/mus.22232 . This paper describes the role of TGFb in skeletal muscle weakness. This was the first report of muscle functional status modulation directly by TGFb","journal-title":"Muscle Nerve"},{"issue":"11","key":"344_CR29","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1007\/s00520-013-1876-6","volume":"21","author":"K Lam","year":"2013","unstructured":"Lam K, Chow E, Zhang L, Wong E, Bedard G, Fairchild A, et al. Determinants of quality of life in advanced cancer patients with bone metastases undergoing palliative radiation treatment. Support Care Cancer. 2013;21(11):3021\u201330. doi: 10.1007\/s00520-013-1876-6 .","journal-title":"Support Care Cancer"},{"issue":"8","key":"344_CR30","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1002\/cncr.22991","volume":"110","author":"F Saad","year":"2007","unstructured":"Saad F, Lipton A, Cook R, Chen YM, Smith M, Coleman R. Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer. 2007;110(8):1860\u20137. doi: 10.1002\/cncr.22991 .","journal-title":"Cancer"},{"issue":"2","key":"344_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147(2):275\u201392. doi: 10.1016\/j.cell.2011.09.024 .","journal-title":"Cell"},{"issue":"6","key":"344_CR32","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ccr.2011.11.002","volume":"20","author":"X Lu","year":"2011","unstructured":"Lu X, Mu E, Wei Y, Riethdorf S, Yang Q, Yuan M, et al. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging alpha4beta1-positive osteoclast progenitors. Cancer Cell. 2011;20(6):701\u201314. doi: 10.1016\/j.ccr.2011.11.002 .","journal-title":"Cancer Cell"},{"issue":"3","key":"344_CR33","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S0002-9440(10)65628-3","volume":"153","author":"KJ Luzzi","year":"1998","unstructured":"Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol. 1998;153(3):865\u201373. doi: 10.1016\/S0002-9440(10)65628-3 .","journal-title":"Am J Pathol"},{"issue":"17","key":"344_CR34","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.1158\/1078-0432.CCR-07-0024","volume":"13","author":"MA Watson","year":"2007","unstructured":"Watson MA, Ylagan LR, Trinkaus KM, Gillanders WE, Naughton MJ, Weilbaecher KN, et al. Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients. Clin Cancer Res. 2007;13(17):5001\u20139. doi: 10.1158\/1078-0432.CCR-07-0024 .","journal-title":"Clin Cancer Res"},{"issue":"6","key":"344_CR35","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc3055","volume":"11","author":"KN Weilbaecher","year":"2011","unstructured":"Weilbaecher KN, Guise TA, McCauley LK. Cancer to bone: a fatal attraction. Nat Rev Cancer. 2011;11(6):411\u201325. doi: 10.1038\/nrc3055 .","journal-title":"Nat Rev Cancer"},{"issue":"33","key":"344_CR36","doi-asserted-by":"publisher","first-page":"25103","DOI":"10.1074\/jbc.R109.041087","volume":"285","author":"LJ Raggatt","year":"2010","unstructured":"Raggatt LJ, Partridge NC. Cellular and molecular mechanisms of bone remodeling. J Biol Chem. 2010;285(33):25103\u20138. doi: 10.1074\/jbc.R109.041087 .","journal-title":"J Biol Chem"},{"issue":"1","key":"344_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bone.2010.10.159","volume":"49","author":"MR Allen","year":"2011","unstructured":"Allen MR, Burr DB. Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know. Bone. 2011;49(1):56\u201365. doi: 10.1016\/j.bone.2010.10.159 .","journal-title":"Bone"},{"issue":"39","key":"344_CR38","doi-asserted-by":"publisher","first-page":"13909","DOI":"10.1073\/pnas.0506517102","volume":"102","author":"Y Kang","year":"2005","unstructured":"Kang Y, He W, Tulley S, Gupta GP, Serganova I, Chen CR, et al. Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc Natl Acad Sci U S A. 2005;102(39):13909\u201314. doi: 10.1073\/pnas.0506517102 .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"344_CR39","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003;3(6):537\u201349.","journal-title":"Cancer Cell"},{"issue":"8","key":"344_CR40","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/nm.1943","volume":"15","author":"M Korpal","year":"2009","unstructured":"\u2022 Korpal M, Yan J, Lu X, Xu S, Lerit DA, Kang Y. Imaging transforming growth factor-beta signaling dynamics and therapeutic response in breast cancer bone metastasis. Nat Med. 2009;15(8):960\u20136. doi: 10.1038\/nm.1943 . This paper describes the utility of TGFb inhibition in early bone metastases and shows that the largest source of TGFb in mice with osteolytic breast cancer bone metastases is from the mineralized bone matrix","journal-title":"Nat Med"},{"issue":"2","key":"344_CR41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1172\/JCI3523","volume":"103","author":"JJ Yin","year":"1999","unstructured":"Yin JJ, Selander K, Chirgwin JM, Dallas M, Grubbs BG, Wieser R, et al. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest. 1999;103(2):197\u2013206. doi: 10.1172\/JCI3523 .","journal-title":"J Clin Invest"},{"issue":"11","key":"344_CR42","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/nm.3961","volume":"21","author":"DL Waning","year":"2015","unstructured":"\u2022\u2022 Waning DL, Mohammad KS, Reiken S, Xie W, Andersson DC, John S, et al. Excess TGF-beta mediates muscle weakness associated with bone metastases in mice. Nat Med. 2015;21(11):1262\u201371. doi: 10.1038\/nm.3961 . This paper describes the novel TGFb-Nox4-RyR1 axis that is altered in osteolytic cancer in the bone. The mechanism of muscle weakness in these studies is via increased oxidative stress and sarcoplamic reticulum calcium leak","journal-title":"Nat Med"},{"issue":"2","key":"344_CR43","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cmet.2011.05.014","volume":"14","author":"DC Andersson","year":"2011","unstructured":"Andersson DC, Betzenhauser MJ, Reiken S, Meli AC, Umanskaya A, Xie W, et al. Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. Cell Metab. 2011;14(2):196\u2013207. doi: 10.1016\/j.cmet.2011.05.014 .","journal-title":"Cell Metab"},{"issue":"3","key":"344_CR44","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nm.1916","volume":"15","author":"AM Bellinger","year":"2009","unstructured":"Bellinger AM, Reiken S, Carlson C, Mongillo M, Liu X, Rothman L, et al. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med. 2009;15(3):325\u201330. doi: 10.1038\/nm.1916 .","journal-title":"Nat Med"},{"issue":"9","key":"344_CR45","doi-asserted-by":"publisher","first-page":"e6896","DOI":"10.1371\/journal.pone.0006896","volume":"4","author":"LK Dunn","year":"2009","unstructured":"Dunn LK, Mohammad KS, Fournier PG, McKenna CR, Davis HW, Niewolna M, et al. Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment. PLoS One. 2009;4(9):e6896. doi: 10.1371\/journal.pone.0006896 .","journal-title":"PLoS One"},{"issue":"2","key":"344_CR46","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1161\/01.CIR.0000105680.92873.70","volume":"109","author":"T Ago","year":"2004","unstructured":"Ago T, Kitazono T, Ooboshi H, Iyama T, Han YH, Takada J, et al. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation. 2004;109(2):227\u201333. doi: 10.1161\/01.CIR.0000105680.92873.70 .","journal-title":"Circulation"},{"issue":"21","key":"344_CR47","doi-asserted-by":"publisher","first-page":"7715","DOI":"10.1021\/jm100773e","volume":"53","author":"B Laleu","year":"2010","unstructured":"Laleu B, Gaggini F, Orchard M, Fioraso-Cartier L, Cagnon L, Houngninou-Molango S, et al. First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis. J Med Chem. 2010;53(21):7715\u201330. doi: 10.1021\/jm100773e .","journal-title":"J Med Chem"},{"key":"344_CR48","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.lfs.2015.10.023","volume":"143","author":"EM Lee","year":"2015","unstructured":"Lee EM, Kim DY, Kim AY, Lee EJ, Kim SH, Lee MM, et al. Chronic effects of losartan on the muscles and the serologic profiles of mdx mice. Life Sci. 2015;143:35\u201342. doi: 10.1016\/j.lfs.2015.10.023 .","journal-title":"Life Sci"},{"issue":"1","key":"344_CR49","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/mus.21869","volume":"43","author":"AP Taniguti","year":"2011","unstructured":"Taniguti AP, Pertille A, Matsumura CY, Santo Neto H, Marques MJ. Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-beta1 blocker. Muscle Nerve. 2011;43(1):82\u20137. doi: 10.1002\/mus.21869 .","journal-title":"Muscle Nerve"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-017-0344-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-017-0344-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-017-0344-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T13:35:18Z","timestamp":1658583318000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-017-0344-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["344"],"URL":"https:\/\/doi.org\/10.1007\/s11914-017-0344-5","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}